Back to 
State Street Corp.
State Street Corp.
ACHN
Showing 0 of 3 quarters
Position history for State Street Corp.'s holdings in ACHILLION PHARMACEUTICALS
As of its Q4 2019 13F, State Street held 5,143,739 shares of ACHN (Achillion Pharmaceuticals), worth $31M. State Street's 13F filings listed ACHN from Q3 2019 to Q4 2019, 2 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ACHN: RTW Investments, LP, Dimensional Fund Advisors LP, Pentwater Capital Management LP